Log inSupport Us
opengovt
Lobbying
← Back
Lobbying · Company

GSK

Meetings with ministers

67

In the last 12 months

12

Different ministers

23

Lobbying firms used

1

Meetings with ministers

DateMinisterPurpose, as published
16 June 2026Nick Thomas-SymondsCabinet OfficeA meeting to discuss UK-EU relations
19 March 2026Dr Zubir AhmedDHSCRoundtable to discuss Pathogen Access and Benefit-Sharing
5 March 2026Jason StockwoodDBTTo discuss the UK life sciences investment environment
4 March 2026Wes StreetingDHSCTo discuss medicines pricing
4 March 2026Dr Zubir AhmedDHSCTo discuss medicines pricing
4 March 2026Sir Keir StarmerPrime MinisterVideo meeting to discuss UK competitiveness and investment opportunities in the pharmaceutical and life sciences sectors
19 February 2026Patrick VallanceDSITTo discuss the UK Life Sciences sector.
11 February 2026Patrick VallanceDSITTo discuss collaboration opportunities and recent developments in research.
10 February 2026Dr Zubir AhmedDHSCTo discuss life sciences priorities
30 January 2026Sir Keir StarmerPrime MinisterDrop-in to Life Sciences Roundtable for brushby introductions
13 January 2026Patrick VallanceDSITTo discuss UK Life Sciences sector.
12 November 2025Sir Keir StarmerPrime MinisterInformal meeting with British Business leaders to discuss the economy, the UK business environment and the Government’s delivery agenda
23 September 2025Chris BryantDBTTo discuss UK-Brazilian trade
3 September 2025David LammyFCDOTo engage with high level UK businesses to build upon UK growth opportunities.
6 June 2025Patrick VallanceDSITTo discuss translational research networks
2 June 2025Patrick VallanceDSITTo discuss the pharmaceutical landscape in the UK
14 May 2025Ashley DaltonDHSCTo engage with vaccines stakeholders on vaccine delivery
8 May 2025Patrick VallanceDSITTo discuss the Life Sciences Sector Plan
8 May 2025Sir Keir StarmerPrime MinisterVideo meeting with business leaders during visit to discuss the US trade deal
22 April 2025Darren JonesHMTA roundtable discussion around the Spending Review and major capital projects
11 April 2025James MurrayHMTTo discuss the impact of the Corporate Tax Roadmap
3 April 2025Sir Keir StarmerPrime MinisterBusiness roundtable to discuss UK-US trade talks with British businesses
2 April 2025Wes StreetingDHSCTo discuss life sciences
2 April 2025Wes StreetingDHSCTo discuss life sciences
2 April 2025Rachel ReevesHMTMeeting to discuss investment ahead of the Biopharmaceutical CEO Roundtable
2 April 2025Sir Keir StarmerPrime MinisterBiopharmaceuticals CEOs Roundtable to discuss global health challenges and life sciences policy
2 April 2025Peter KyleDSITRoundtable discuss issues facing life sciences in the UK, including VPAG, clincial trials, and health data
2 April 2025Wes StreetingDHSCTo discuss life sciences
2 April 2025Jonathan ReynoldsDBTTo discuss the policy environment for the life sciences sector in the UK
2 April 2025Poppy GustafssonDBTTo discuss the UK life sciences commerical environment and investment in this sector
2 April 2025Wes StreetingDHSCTo discuss life sciences
2 April 2025Patrick VallanceDSITBiopharmaceutical CEO Roundtable (BCR) Ministerial Policy Roundtable
31 March 2025Nick Thomas-SymondsCabinet OfficeRoundtable with European industry to understand where the biggest barriers to trade with the UK lie.
27 March 2025Patrick VallanceDSITTo discuss company views on the industrial strategy
26 March 2025Douglas AlexanderDBTTo engage with UK businesses with Polish presence on UK-Poland trade and UK business footprint in Poland
24 March 2025Patrick VallanceDSITAttendance at a roundtable alongside key stakeholders, to discuss the UK Government�s ambition for life sciences and priorities and perspectives on dementia research and new treatments.
20 March 2025Emma ReynoldsHMTMeeting with the Capital Markets Industry Taskforce to discuss increasing the international competitiveness of the UK capital markets
7 March 2025Patrick VallanceDSITTo discuss Lord Vallance's new role as Oxford-Cambridge Growth Corridor champion
4 March 2025Douglas AlexanderDBTTo discuss the current trading environment
12 February 2025Seema MalhotraHome OfficeRoundtable convened by Change the Race: Ratio to discuss pay gap reporting.
6 February 2025Patrick VallanceDSITRoundtable on Mathematical Sciences to discuss the challenges and opportunities for the Maths sector.
5 February 2025Wes StreetingDHSCTo discuss life sciences
4 February 2025Patrick VallanceDSITVisit for World Cancer Day. Discussion around how the response research program improves the effectiveness of treatments.
30 January 2025Patrick VallanceDSITTo discuss progress and priorities for advancing growth in the life sciences sector.
29 January 2025Nick Thomas-SymondsCabinet OfficeRoundtable discussion on ambitions for the UK/EU reset.
28 January 2025Rachel ReevesHMTRoundtable to discuss growth and regulation
27 January 2025Peter KyleDSITEvent to discuss the Oxford-Cambridge Arc, and the actions Government can take to support economic growth in the area, eg. the development of infrastructure
27 January 2025Patrick VallanceDSITTo discuss OxCam Supercluster report
27 November 2024Pat McFaddenCabinet OfficeA briefing to CNI owners and operators
21 November 2024Emma ReynoldsDWPTo discuss the Pensions Investment Review
24 October 2024Andrew GwynneDHSCTo discuss the Pandemic Accord.
22 October 2024Wes StreetingDHSCTo discuss life sciences at the Life Sciences Council
22 October 2024Wes StreetingDHSCTo discuss medical research
22 October 2024Patrick VallanceDSITMeeting of the Life Sciences Council.
22 October 2024Peter KyleDSITTo discuss priorities for the life sciences council and key issues for the sector.
22 October 2024Gillian MerronDHSCto discuss life sciences
22 October 2024Wes StreetingDHSCTo discuss life sciences and the UK's investment environment
15 October 2024Mary CreaghDefraTo discuss perspecties on the use of Digital Sequencing Information on genetic resources, ahead of the Convention on Biological Diversity.
14 October 2024Patrick VallanceDSITTo discuss investment in the UK.
14 October 2024Rachel ReevesHMTRoundtable at the International Investment Summit to discuss the UK's Life Sciences sector.
13 October 2024Keir StarmerPrime MinisterInformal engagement at No 10 prior to the International Investment Summit
16 September 2024Patrick VallanceDSITTo discuss life sciences policy
9 September 2024Rachel ReevesHMT ministerial meetings July to September 2024To discuss the role of the Life Sciences sector in the UK's economic growth and Industrial Strategy.
9 September 2024Peter KyleDSITTo discuss GSK's footprint in the UK and the Government's ambitions for life sciences and industrial strategy
5 September 2024Patrick VallanceDSITTo discuss alternatives to the use of animals in science
15 August 2024Patrick VallanceDSITTo discuss life sciences and growth in the UK
31 July 2024Emma ReynoldsDWPTo hear their initial views and discuss the Pensions Review

Consultant lobbying firms

  • Global Counsel Ltd
    July to September 2024
About these records. Each row is one entry in a minister’s published meetings return, so a meeting with two ministers appears once for each. Dates and purposes are shown as the department published them. Published under these names too: “GlaxoSmithKline”, “GSK plc”, “GlaxoSmithKline (GSK)”, “GlaxoSmithKline Plc”. Sources: GOV.UK ministers’ meetings transparency returns and the Registrar of Consultant Lobbyists quarterly returns, both under the Open Government Licence v3.0.